fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Mutual Funds » UTI Healthcare Fund

UTI Healthcare Fund - G

NAV  ₹122.34 ↓ -0.12  (-0.10 %) as on 7 Aug 20

(Erstwhile UTI Pharma & Healthcare Fund)

Scheme Objective

The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors.

UTI Healthcare Fund is a Equity - Sectoral fund launched on 28 Jun 99. It is a fund with High risk and has given a CAGR return of 14.1% since its launch.  Ranked 40 in Sectoral category.  Return for 2019 was 1.2% , 2018 was -7.5% and 2017 was 6.2% .

Below is the key information for UTI Healthcare Fund

NAV as on 7 Aug 20₹122.34 ↓ -0.12  (-0.10 %)
Net Assets (AUM) as on 30 Jun 2020 ₹481 Cr.
Launch Date28 Jun 1999
CategoryEquity - Sectoral
Rating
TypeOpen Ended Fund
RiskHigh
AMCUTI Asset Management Company Ltd
Alpha Ratio5.51
Expense Ratio2.77 %
Sharpe Ratio1.054
Information Ratio0.38
BenchmarkNot Available
Min Investment ₹5,000
Min SIP Investment ₹500
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Returns

Annual Compounded Returns

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 7 Aug 20

DurationReturns
1 Month 16.7%
3 Month 24%
6 Month 35.7%
1 Year 56.2%
3 Year 13%
5 Year 4.4%
10 Year
15 Year
Since launch 14.1%

Historical Annual Returns

Historical performance (Yearly) on absolute basis

YearReturns
2019 1.2%
2018 -7.5%
2017 6.2%
2016 -9.7%
2015 12.4%
2014 43.7%
2013 23.3%
2012 24.8%
2011 -9.6%

Growth of 10k Over Years

DateValue
31 Jul 15₹10,000
31 Jul 16₹9,716
31 Jul 17₹8,884
31 Jul 18₹8,932
31 Jul 19₹8,096
31 Jul 20₹12,276
UTI Healthcare Fund Growth 10k Chart

Asset Allocation

Asset ClassValue
Cash1.11%
Equity98.89%
UTI Healthcare Fund Asset Allocation

Sector Allocation

SectorValue
Health Care97.48%
Basic Materials1.41%
UTI Healthcare Fund Equity Allocation

Top Securities Holdings / Portfolio

Holdings/Securities

NameGlobal IndustryHoldingValueQuantity
Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | 500124
Drug Manufacturers - Specialty & Generic11%₹52 Cr132,944
Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA
Drug Manufacturers - Specialty & Generic10%₹50 Cr1,051,975
↑ 278,460
Aurobindo Pharma Ltd (Healthcare)
Equity, Since 31 Oct 13 | AUROPHARMA
Drug Manufacturers - Specialty & Generic9%₹41 Cr537,031
Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | 500087
Drug Manufacturers - General7%₹34 Cr531,236
↓ -137,172
Biocon Ltd (Healthcare)
Equity, Since 31 Oct 18 | 532523
Biotechnology6%₹29 Cr745,974
↑ 20,000
Ipca Laboratories Ltd (Healthcare)
Equity, Since 31 Jan 14 | 524494
Drug Manufacturers - Specialty & Generic6%₹27 Cr161,673
↑ 16,852
Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB
Drug Manufacturers - Specialty & Generic5%₹26 Cr113,782
↓ -10,000
Lupin Ltd (Healthcare)
Equity, Since 31 May 18 | 500257
Drug Manufacturers - Specialty & Generic5%₹26 Cr283,686
↓ -79,387
Cadila Healthcare Ltd (Healthcare)
Equity, Since 31 Jan 03 | 532321
Drug Manufacturers - Specialty & Generic5%₹22 Cr631,281
↓ -64,377
Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | 532331
Drug Manufacturers - Specialty & Generic4%₹19 Cr136,317
1 - 10 of 26
Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Fund Managers

NameSinceTenure
V Srivatsa3 Mar 173.33 Yr.

Custodians

CompanyAddress
Bank of Nova Scotia12/13, Maker Chamber VI,220, Nariman Point
Citibank N.A. IndiaTrent House, 3rd Floor, G Block,,Plot No.60, Next to Citibank,,Bandra Kurla Complex,,Bandra (East),
Stock Holding Corporation of IndiaMittal Court, ‘B’ Wing,,Nariman Point

Registrar & Transfer Agent

KFin Technologies Private Limited
Address"KARVY HOUSE",46, Avenue 4, Street No.1,,Banjara Hills,
FAX91-40-23311968
Emailmailmanager@karvy.com

Administrator Companies

CompanyAddress
UTI Mutual FundUTI Tower , `GN' Block,,Bandra Kurla Complex,,Bandra (E)

Auditors

CompanyAddress
Haribhakti & Co. Chartered Accountants42, Free Press House,4th Floor,,215, Nariman Point,

All Plan & Options

Fund and PlanNAV6 Month1 Year3 Year5 Year
UTI Healthcare Fund
Growth
₹122.34
↓ -0.12
35.74 %56.18 %12.96 %4.36 %
UTI Healthcare Fund
Normal Dividend, Payout
₹94.5517
↓ -0.09
35.74 %56.18 %12.96 %4.36 %
UTI Healthcare Fund
Normal Dividend, Reinvestment
₹94.5517
↓ -0.09
35.74 %56.18 %12.96 %4.36 %
Data as on 7 Aug 20

Disclaimer:
All efforts have been made to ensure the information provided here is accurate. However, no guarantees are made regarding correctness of data.